These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33663463)

  • 1. Predictors of a placebo response in patients with hand osteoarthritis: post-hoc analysis of two randomized controlled trials.
    Park JK; Ahn SH; Shin K; Lee YJ; Song YW; Lee EB
    BMC Musculoskelet Disord; 2021 Mar; 22(1):244. PubMed ID: 33663463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Tolerability of GCSB-5 for Hand Osteoarthritis: A Randomized, Controlled Trial.
    Park JK; Shin K; Kang EH; Ha YJ; Lee YJ; Lee KH; Lee EY; Song YW; Choi Y; Lee EB
    Clin Ther; 2016 Aug; 38(8):1858-1868.e2. PubMed ID: 27449412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of diacerein in hand osteoarthritis: a double-blind, randomized, placebo-controlled study.
    Shin K; Kim JW; Moon KW; Yang JA; Lee EY; Song YW; Lee EB
    Clin Ther; 2013 Apr; 35(4):431-9. PubMed ID: 23474153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.
    Barthel HR; Peniston JH; Clark MB; Gold MS; Altman RD
    Arthritis Res Ther; 2010; 12(1):R7. PubMed ID: 20064249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.
    Aitken D; Laslett LL; Pan F; Haugen IK; Otahal P; Bellamy N; Bird P; Jones G
    Osteoarthritis Cartilage; 2018 Jul; 26(7):880-887. PubMed ID: 29499287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal clinically important decline in physical function over one year: EPOSA study.
    Siviero P; Limongi F; Gesmundo A; Zambon S; Cooper C; Dennison EM; Edwards MH; Timmermans EJ; van der Pas S; Schaap LA; van Schoor NM; Denkinger MD; Herbolsheimer F; Peter R; Castell MV; Otero Á; Queipo R; Pedersen NL; Deeg DJH; Maggi S;
    BMC Musculoskelet Disord; 2019 May; 20(1):227. PubMed ID: 31101033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial.
    Schett G; Bainbridge C; Berkowitz M; Davy K; Fernandes S; Griep E; Harrison S; Gupta A; Lloyd-Hughes J; Roberts A; Layton M; Nowak NA; Patel J; Rech J; Smith JE; Watts S; Tak PP
    Lancet Rheumatol; 2020 Oct; 2(10):e623-e632. PubMed ID: 38273625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
    Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
    Trials; 2014 Oct; 15():412. PubMed ID: 25348033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lee W; Ruijgrok L; Boxma-de Klerk B; Kok MR; Kloppenburg M; Gerards A; Huisman M; Hazes M; de Sonnaville P; Grillet B; Weel A; Basoski N
    Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1320-1325. PubMed ID: 29125901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity, factor structure, and clinical relevance of the AUSCAN Osteoarthritis Hand Index.
    Allen KD; Jordan JM; Renner JB; Kraus VB
    Arthritis Rheum; 2006 Feb; 54(2):551-6. PubMed ID: 16447231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.
    Wenham CY; Hensor EM; Grainger AJ; Hodgson R; Balamoody S; Doré CJ; Emery P; Conaghan PG
    Rheumatology (Oxford); 2012 Dec; 51(12):2286-94. PubMed ID: 22956551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
    Kedor C; Detert J; Rau R; Wassenberg S; Listing J; Klaus P; Braun T; Hermann W; Weiner SM; Buttgereit F; Burmester GR
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34215704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial.
    Altman RD; Dreiser RL; Fisher CL; Chase WF; Dreher DS; Zacher J
    J Rheumatol; 2009 Sep; 36(9):1991-9. PubMed ID: 19648310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The responsiveness of joint counts, patient-reported measures and proposed composite scores in hand osteoarthritis: analyses from a placebo-controlled trial.
    Haugen IK; Slatkowsky-Christensen B; Lessem J; Kvien TK
    Ann Rheum Dis; 2010 Aug; 69(8):1436-40. PubMed ID: 19508966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of erosive joints is a strong predictor of radiological progression in hand osteoarthritis: results of a 2-year prospective follow-up of the Liège Hand Osteoarthritis Cohort (LIHOC).
    Neuprez A; Kaux JF; Locquet M; Beaudart C; Reginster JY
    Arthritis Res Ther; 2021 Jan; 23(1):12. PubMed ID: 33407767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.
    Kloppenburg M; Peterfy C; Haugen IK; Kroon F; Chen S; Wang L; Liu W; Levy G; Fleischmann RM; Berenbaum F; van der Heijde D; Bansal P; Wittoek R; Feng S; Fang Y; Saltarelli M; Medema JK; Levesque MC
    Ann Rheum Dis; 2019 Mar; 78(3):413-420. PubMed ID: 30552176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis.
    Kvien TK; Fjeld E; Slatkowsky-Christensen B; Nichols M; Zhang Y; Prøven A; Mikkelsen K; Palm Ø; Borisy AA; Lessem J
    Ann Rheum Dis; 2008 Jul; 67(7):942-8. PubMed ID: 17962237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC).
    Neuprez A; Bruyère O; Maheu E; Dardenne N; Burlet N; D'Hooghe P; Distèche S; Reginster JY
    Arthritis Res Ther; 2015 Nov; 17():346. PubMed ID: 26620999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.